semaglutide 50 Study reveals oral mg as promising treatment for obesity in adults: the Lancet report Compounded Sublingual Semaglutide - YourSkinnyRx

Originally developed for diabetes and weight loss, GLP-1 medications may help quiet the brains reward circuitry, muting the intense craving signals associated with Substance Use Disorders

The company is planning another Phase 2b trial to assess multiple monthly doses in obesity with preliminary data expected in ear-end-2025 or early-2026

This medication may help individuals feel less hungry, consume less food, and consequently lose weight

Its great to see how this aligns with the Pivot to Growth strategy and strengthens the complex generics portfolio

Researchers noticed that the stomach, despite being exposed to acid that would destroy most tissues, is remarkably self-repairing